Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Timms

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
The Lancet. Respiratory Medicine|December 6, 2014
Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trialAdrian R Martineau, Wai Yee James, Richard L Hooper, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2012
Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatmentAnna K Coussens, Robert J Wilkinson, Yasmeen Hanifa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerMelinda L Telli, Kirsten M Timms, Julia Reid, et al.
Thorax|March 1, 2015
Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs)Adrian R Martineau, Beverley D MacLaughlin, Richard L Hooper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2018
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixtoS Loibl, K E Weber, K M Timms, et al.
Lancet (London, England)|January 11, 2011
High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trialAdrian R Martineau, Peter M Timms, Graham H Bothamley, et al.
Human Molecular Genetics|June 19, 2015
AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemiaElizabeth L Virts, Anna Jankowska, Craig Mackay, et al.
Breast Cancer Research and Treatment|August 17, 2023
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypesLauren Lenz, Chris Neff, Cara Solimeno, et al.
Journal of the National Cancer Institute|May 16, 2020
BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-AnalysisRoshni D Kalachand, Britta Stordal, Stephen Madden, et al.
Nature Medicine|May 2, 2018
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT TrialAndrew Tutt, Holly Tovey, Maggie Chon U Cheang, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
The Lancet. Respiratory Medicine|December 6, 2014
Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trialAdrian R Martineau, Wai Yee James, Richard L Hooper, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2012
Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatmentAnna K Coussens, Robert J Wilkinson, Yasmeen Hanifa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerMelinda L Telli, Kirsten M Timms, Julia Reid, et al.
Thorax|March 1, 2015
Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs)Adrian R Martineau, Beverley D MacLaughlin, Richard L Hooper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2018
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixtoS Loibl, K E Weber, K M Timms, et al.
Lancet (London, England)|January 11, 2011
High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trialAdrian R Martineau, Peter M Timms, Graham H Bothamley, et al.
Human Molecular Genetics|June 19, 2015
AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemiaElizabeth L Virts, Anna Jankowska, Craig Mackay, et al.
Breast Cancer Research and Treatment|August 17, 2023
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypesLauren Lenz, Chris Neff, Cara Solimeno, et al.
Journal of the National Cancer Institute|May 16, 2020
BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-AnalysisRoshni D Kalachand, Britta Stordal, Stephen Madden, et al.
Nature Medicine|May 2, 2018
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT TrialAndrew Tutt, Holly Tovey, Maggie Chon U Cheang, et al.
Pageof 18